Seven days after intravitreal injection of aflibercept plasma levels were significantly reduced to values below the minimum detectable dose ( MDD ) in 17 of 19 patients ( 89.5 % ) resulting in a median VEGF concentration of < 9 pg/ml ( p < 0.001 ) .